Monthly Archives: June 2018

CSM Researchers and collaborators discover predictive biomarker for key colorectal cancer drug

Scientists discover predictive biomarker for key colorectal cancer drug Friday, 01 June 2018: The ANGIOPREDICT research consortium have discovered a potential biomarker that can predict which patients will receive most benefit from a key drug used to treat colorectal cancer (Avastin). … Continue reading

Posted in News | Comments Off on CSM Researchers and collaborators discover predictive biomarker for key colorectal cancer drug